Returns
NAV and returns as at 20 Aug 2026
Lumpsum · point to point
1W
-0.33%
1M
+1.84%
3M
+10.29%
6M
+23.39%
YTD
+23.77%
1Y
+20.09%
2Y CAGR
+15.71%
3Y CAGR
+24.31%
5Y CAGR
+19.34%
10Y CAGR
+15.06%
SIP · XIRR on monthly instalments
6M SIP
+60.83%
1Y SIP
+35.77%
2Y SIP
+20.86%
3Y SIP
+22.03%
5Y SIP
+23.63%
10Y SIP
+20.77%
Full history SIP
+20.77%
Periods up to one year are absolute; longer periods are annualised (CAGR). SIP figures are the XIRR of a fixed monthly instalment over the same window. — means this scheme’s NAV history does not cover that period — across all 1648 schemes, 68% have a 3-year figure, 48.8% a 5-year one, and 32.7% a 10-year one.
Top holdings
as at 31 Jul 2026 · source: AMC monthly portfolio disclosure
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology
12.72%
Divi's Laboratories Ltd.Pharmaceuticals & Biotechnology
7.46%
Acutaas Chemicals Ltd.Pharmaceuticals & Biotechnology
5.17%
Cipla Ltd.Pharmaceuticals & Biotechnology
5.07%
Apollo Hospitals Enterprise Ltd.Healthcare Services
4.98%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology
4.74%
Max Healthcare Institute Ltd.Healthcare Services
4.58%
Laurus Labs Ltd.Pharmaceuticals & Biotechnology
4.04%
Aurobindo Pharma Ltd.Pharmaceuticals & Biotechnology
3.86%
Aster DM Quality Care Ltd.Healthcare Services
3.65%
Top 10 56.27%Securities 34Securities total 98.36%Cash & equivalents 1.64%
The ten largest securities by weight, out of 34 disclosed. Weight is percent of net assets as filed. Cash-equivalent lines (TREPS, reverse repo, net receivables, margin) and derivative legs are counted in the chips above but not ranked among securities, because a short futures leg is filed as a negative weight and sorting it alongside a shareholding describes no portfolio. A portfolio is a point-in-time filing and changes every month.
Risk
Volatility · annualised · 3Y
14.03%
Volatility is the annualised standard deviation of daily NAV moves over the last three years; max drawdown is the deepest peak-to-trough fall in that same window. Where a scheme has less than three years of NAV, the window is what it actually has and is labelled as such — never as three years. Sharpe is as disclosed in the scheme key-ratio feed (as at 24 July 2026).
Beta and alpha are not shown. No benchmark series in the source.
Cost
Expense ratio—
Category average—
Exit load—
52W high / low₹607.9991 / ₹462.8741
The expense ratio for this scheme is not disclosed in this dataset.
Expense ratio and category average are as disclosed against this scheme in the source; 78.5% of schemes here carry one. The ratio is charged inside the NAV, so every return on this page is already net of it.
Scheme facts
SEBI sub-category
Sectoral/ Thematic
Plan / option
—
Benchmark
—
Fund manager
—
Launched
01 Jan 1993
NAV history here
10.0y
ISIN
INF200K01UP2
AMFI scheme code
119783
SEBI riskometer
—
Exit load
—
Lock-in
—
Minimum lumpsum
₹5,000
Exit load is not disclosed for this scheme in this dataset.
Not shown on this page, and why
Star rating — GFS is an AMFI-registered distributor (ARN-169480), not a SEBI-registered investment adviser. It does not rate schemes.
Scheme AUM — Scheme-level AUM is not in the source; only AMC-total AUM, which is a different number.
Minimum SIP — Not present in the source.
Beta and alpha — No benchmark series in the source.